Refine by
Cardiac Emergency Articles & Analysis
4 news found
The acquisition will complement the existing Boston Scientific electrophysiology portfolio to include the FARAPULSE Pulsed Field Ablation (PFA) System – a non-thermal ablation system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias. "The emerging field of PFA has the potential to alter the future of ablation therapy and has shown ...
KEY POINTS Cardiac arrest is one of the leading causes of death in the U.S. and globally. ...
The approval is based on the results of the landmark Lipid-Rich Plaque (LRP) Study, which demonstrated the ability of intravascular ultrasound (IVUS) and near-infrared spectroscopy (NIRS) technology to identify patients and coronary plaques at an increased risk for major adverse cardiac events (MACE). The study, which enrolled 1,563 patients from 44 sites across the U.S. and ...
EndoLogic announced that the FDA accepted the cardiac safety trial for renzapride in patients with gastroparesis. That study demonstrated no evidence of QTc prolongation in the EKG findings. ...